LAILIXIN - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
76682427
Word Mark
LAILIXIN
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2011-10-20
Filing Date
2007-10-01
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2008-09-09
Attorney Name
Law Office Assigned Location Code
M30
Employee Name
SPRUILL, DARRYL M
Statements
Goods and Services
Full line of bulk pharmaceuticals, pharmaceutical intermediates, pharmaceutical preparations, antibiotics for animals and humans, animal feed supplements, human food supplements, herbal supplements for animals and humans, mineral supplements for animals and humans, dietary supplements for animals and humans, and vitamins for animals and humans in the form of caplets, capsules, creams, drops, douches, foams, gel-tabs, gels, inhalants, injectables, lotions, ointments, pastilles, powders, rinses, shampoos, solutions, spansules, sponges, sprays, suppositories, syrups and tablets including Ace-inhibitors; Adrenergic agonists; Adrenergic blockers; Anabolics; Analgesics, narcotic and non-narcotic analgesics; Anesthetics; Antianorexics; Antacids; Anthelmintics; Antiacnes; Antiallergics; Antianginals; Antiarthritics and antirheumatics; Antiasthmatics; Antibacterials; Antibiotics; Anticoagulants; Anticonvulsants; Antidepressants; Antidiabetics; Antidiarrheals; Antidiuretics; Antiemetics; Antifungals; Antiglaucomas; Antihistaminics; Antihypertensives; Antihyperthyroids; Antihypotensives; Anti-inflammatories; Anti-itch creams, ointments and sprays; Antimalarials; Antimigraines; Antimuscarinics; Antineoplastics; Antioxidants; Antiparkinsonians; Antiprotozoals; Antipruritics; Antipsoriatics; Antipsychotics; Antiseborrheics; Antiseptics; Antispasmodics; Antisyphilitics; Antithrombotics; Antitussives; Antiulceratives; Antivirals; Anxiolyties; Astringents; Bacteriostats for medicinal, dental and veterinary use; Bath salts for medical purposes; Beta-blockers; Biocides; Biological and chemical reagents for medical or veterinary use; Bronchodilators; Burn-relief medications; Calcium channel blockers; Cardiotonics; nutritional additives for use in dietary supplements, namely, carotenoids; Chemotherapeutics; Choleretics; Cholesterol reducers; Cholinergics; Cholinesterase inhibitors; Cleansing solutions for medical use; Clinical medical reagents; CNS stimulants; Contraceptives; Decongestants; Dermatologicals; Diagnostic preparations for medical purposes; Dietary and nutritional supplements; Diuretics; Dopamine receptor agonists; Enzyme cofactors; Estrogens; Expectorants; Food supplements; Gastric and pancreatic preparations; Germicides; Glucosidase inhibitors; Gonad-stimulating principles; Hematinics; Hematopoietics; Hemostatics; Hepatoprotectants; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Homeopathic supplements; Immunomodulators; Immunosuppressants; Laxatives; Medicinal herbal extracts; Mineral nutritional supplements; Mineralocorticoids; Mixed vitamin preparations; Mucolytics; Multi-vitamin preparations; Muscle relaxants; Mydriatics; Neutraceuticals for use as dietary supplements; Nootropics; Nutritional additives to foodstuffs for animals, for medical purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Plant extracts for medical, veterinary and pharmaceutical purposes; Processed food adapted for medical purposes; Progestogens; Prolactin inhibitors; Prostaglandins and prostaglandin analogs; dietary supplements; Respiratory stimulants; Reverse transcriptase inhibitors; Sedatives; Seratonin receptor agonists and antagonists; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; medicated topical skin protectants for medical use; Vasodilators; Vasoprotectants; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes
Translation of Words in Mark
The wording "LAILIXIN" has no meaning in a foreign language.
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2007-10-09
Primary Code
005
First Use Anywhere Date
2008-07-11
First Use In Commerce Date
2009-10-27
Correspondences
Name
JACK MATALON
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2007-10-09 | NEW APPLICATION ENTERED IN TRAM |
2007-10-13 | APPLICATION FILING RECEIPT MAILED |
2008-01-07 | ASSIGNED TO EXAMINER |
2008-01-10 | NON-FINAL ACTION WRITTEN |
2008-01-10 | NON-FINAL ACTION MAILED |
2008-06-10 | FAX RECEIVED |
2008-06-11 | ASSIGNED TO LIE |
2008-06-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2008-06-16 | AMENDMENT FROM APPLICANT ENTERED |
2008-07-02 | ASSIGNED TO EXAMINER |
2008-07-09 | EXAMINERS AMENDMENT -WRITTEN |
2008-07-09 | EXAMINER'S AMENDMENT ENTERED |
2008-07-09 | EXAMINERS AMENDMENT MAILED |
2008-07-14 | EXAMINERS AMENDMENT -WRITTEN |
2008-07-14 | EXAMINER'S AMENDMENT ENTERED |
2008-07-14 | EXAMINERS AMENDMENT MAILED |
2008-07-30 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2008-08-05 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2008-08-20 | NOTICE OF PUBLICATION |
2008-09-09 | PUBLISHED FOR OPPOSITION |
2008-12-02 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2009-04-28 | TEAS EXTENSION RECEIVED |
2009-04-28 | EXTENSION 1 FILED |
2009-04-28 | EXTENSION 1 GRANTED |
2009-12-01 | TEAS EXTENSION RECEIVED |
2009-12-01 | EXTENSION 2 FILED |
2009-12-01 | EXTENSION 2 GRANTED |
2010-05-19 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2010-05-19 | TEAS STATEMENT OF USE RECEIVED |
2010-06-05 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2010-05-19 | USE AMENDMENT FILED |
2010-06-08 | STATEMENT OF USE PROCESSING COMPLETE |
2010-06-30 | SU - NON-FINAL ACTION - WRITTEN |
2010-07-01 | NON-FINAL ACTION MAILED |
2010-07-19 | PAPER RECEIVED |
2010-07-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2010-07-20 | AMENDMENT FROM APPLICANT ENTERED |
2010-07-21 | ASSIGNED TO EXAMINER |
2010-08-11 | SU - NON-FINAL ACTION - WRITTEN |
2010-08-12 | NON-FINAL ACTION MAILED |
2011-03-13 | SU - FINAL REFUSAL - WRITTEN |
2011-03-14 | FINAL REFUSAL MAILED |
2011-10-20 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2011-10-21 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |